LMAT

Lemaitre Vascular INC

+$684.3M

Net Activity

Institutions Holding

339

Popularity Rank

#1747

Avg Weight

0.10%

Total Value

$2.4B

Ownership Trend

339 institutions currently hold LMAT, with 185 net buyers and 127 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

127

Net Buying Institutions

185

Key Holders

View all 339 holding institutions

Quarterly Activity

Recent Activity

+$1.6B

Total Buy Value

$591.2M

Total Sell Value

New buy64
Trim102
Add121
Sold out25

185

Net Buyers

127

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding LEMAITRE VASCULAR INC (LMAT)?
Major stakeholders currently include BlackRock, Inc. ($343.2M), Conestoga Capital Advisors, LLC ($161.2M), First Trust Advisors LP ($109.0M). Based on the latest 13F filings, there are a total of 339 tracked investment funds and institutions maintaining positions in LMAT.
What is the overall institutional sentiment toward LMAT recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $684.3M, driven by 185 managers accumulating shares while 127 reduced their exposure.
Which institutions have been selling or reducing their LMAT positions?
In the latest period, 102 funds trimmed their holdings, and 25 managers completely exited their positions. The aggregate reported sell value was $591.2M.
Are there any notable investors adding LMAT to their portfolios?
Yes, buying activity remains notable. 64 institutions opened new positions in {ticker}, and 121 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.6B.

Related Stocks